BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35874783)

  • 1. Immunomodulatory Role of Surfactant Protein-D in a Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Model.
    Ganguly K; Kishore U; Metkari SM; Madan T
    Front Immunol; 2022; 13():930449. PubMed ID: 35874783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane Interactome of a Recombinant Fragment of Human Surfactant Protein D Reveals GRP78 as a Novel Binding Partner in PC3, a Metastatic Prostate Cancer Cell Line.
    Thakur G; Sathe G; Kundu I; Biswas B; Gautam P; Alkahtani S; Idicula-Thomas S; Sirdeshmukh R; Kishore U; Madan T
    Front Immunol; 2020; 11():600660. PubMed ID: 33542717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human SP-D Acts as an Innate Immune Surveillance Molecule Against Androgen-Responsive and Androgen-Resistant Prostate Cancer Cells.
    Thakur G; Prakash G; Murthy V; Sable N; Menon S; Alrokayan SH; Khan HA; Murugaiah V; Bakshi G; Kishore U; Madan T
    Front Oncol; 2019; 9():565. PubMed ID: 31355132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells.
    Murugaiah V; Agostinis C; Varghese PM; Belmonte B; Vieni S; Alaql FA; Alrokayan SH; Khan HA; Kaur A; Roberts T; Madan T; Bulla R; Kishore U
    Front Immunol; 2020; 11():1171. PubMed ID: 32733438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Recombinant Fragment of Human Surfactant Protein D induces Apoptosis in Pancreatic Cancer Cell Lines
    Kaur A; Riaz MS; Murugaiah V; Varghese PM; Singh SK; Kishore U
    Front Immunol; 2018; 9():1126. PubMed ID: 29915574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein D.
    Al-Ahdal MN; Murugaiah V; Varghese PM; Abozaid SM; Saba I; Al-Qahtani AA; Pathan AA; Kouser L; Nal B; Kishore U
    Front Immunol; 2018; 9():1586. PubMed ID: 30105014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of p21/Cdkn1a confers protective effect against prostate tumorigenesis in transgenic adenocarcinoma of the mouse prostate model.
    Jain AK; Raina K; Agarwal R
    Cell Cycle; 2013 May; 12(10):1598-604. PubMed ID: 23624841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer.
    Jachetti E; Cancila V; Rigoni A; Bongiovanni L; Cappetti B; Belmonte B; Enriquez C; Casalini P; Ostano P; Frossi B; Sangaletti S; Chiodoni C; Chiorino G; Pucillo CE; Tripodo C; Colombo MP
    Cancer Immunol Res; 2018 May; 6(5):552-565. PubMed ID: 29523597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches.
    Kido LA; de Almeida Lamas C; Maróstica MR; Cagnon VHA
    Life Sci; 2019 Jan; 217():141-147. PubMed ID: 30528182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
    Peek EM; Song W; Zhang H; Huang J; Chin AI
    Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Surfactant Protein D Suppresses Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells by Downregulating TGF-β.
    Kaur A; Riaz MS; Singh SK; Kishore U
    Front Immunol; 2018; 9():1844. PubMed ID: 30158928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of surfactant protein A and D expression decrement and their localizations in human prostate adenocarcinomas.
    Kankavi O; Baykara M; Eren Karanis MI; Bassorgun CI; Ergin H; Ciftcioglu MA
    Ren Fail; 2014 Mar; 36(2):258-65. PubMed ID: 24168624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity.
    Al-Qahtani AA; Murugaiah V; Bashir HA; Pathan AA; Abozaid SM; Makarov E; Nal-Rogier B; Kishore U; Al-Ahdal MN
    Immunobiology; 2019 May; 224(3):408-418. PubMed ID: 30954271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages.
    Cha HR; Lee JH; Hensel JA; Sawant AB; Davis BH; Lee CM; Deshane JS; Ponnazhagan S
    Prostate; 2016 May; 76(7):624-36. PubMed ID: 26856684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant Protein D Reverses the Gene Signature of Transepithelial HIV-1 Passage and Restricts the Viral Transfer Across the Vaginal Barrier.
    Pandit H; Kale K; Yamamoto H; Thakur G; Rokade S; Chakraborty P; Vasudevan M; Kishore U; Madan T; Fichorova RN
    Front Immunol; 2019; 10():264. PubMed ID: 30984160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory therapies in TRAMP mice: delay in PCa progression.
    Kido LA; Montico F; Sauce R; Macedo AB; Minatel E; Costa DB; Carvalho JE; Pilli RA; Cagnon VH
    Endocr Relat Cancer; 2016 Apr; 23(4):235-50. PubMed ID: 26772819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
    Escara-Wilke J; Keller JM; Ignatoski KM; Dai J; Shelley G; Mizokami A; Zhang J; Yeung ML; Yeung KC; Keller ET
    Prostate; 2015 Feb; 75(3):292-302. PubMed ID: 25327941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.
    Hsieh MH; Beirag N; Murugaiah V; Chou YC; Kuo WS; Kao HF; Madan T; Kishore U; Wang JY
    Front Immunol; 2021; 12():641360. PubMed ID: 34054808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).
    da Silva RF; Nogueira-Pangrazi E; Kido LA; Montico F; Arana S; Kumar D; Raina K; Agarwal R; Cagnon VHA
    J Biomed Sci; 2017 May; 24(1):31. PubMed ID: 28499383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological concentration of calcium inhibits elastase-induced cleavage of a functional recombinant fragment of surfactant protein D.
    Duvoix A; Mackay RM; Henderson N; McGreal E; Postle A; Reid K; Clark H
    Immunobiology; 2011; 216(1-2):72-9. PubMed ID: 20378199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.